
Novalitha Pharma Private Limited
About Novalitha Pharma Private Limited
Data last updated:
Novalitha Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24303TG2018PTC126911.
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Surya Rao Easarla (Managing Director) and Veera Venkata Ramana Easarla.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹84.41 Lakh, a decline of 55% compared to the previous year. For the same year it recorded a net loss of ₹8.65 Lakh (net margin -10.2%) and EBITDA of -₹5.68 Lakh (EBITDA margin -6.7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
As per MCA filings, the company has open charges of ₹27 Lakh on record. The company has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9 Lakh; the latest was in February 2021. Its 10 peer companies in the same principal business activity (retail trading) are compared by revenue, 5 larger and 5 smaller; the largest is Abhiraj Agencies Private Limited with revenue of ₹84.48 Lakh.
Company details
Contact details
Novalitha Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressF – 301 7 – 2 – 1735 And 1813/5/A 3rd Floor Sopanam Enclave Czech Colony Sanath Na, Gar, Hyderabad, Telangana, India – 500018
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Novalitha Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novalitha Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Novalitha Pharma Private Limited, buy the company report.
Financials of Novalitha Pharma Private Limited
FY 2023 filings availableNovalitha Pharma Private Limited reported revenue of ₹84.41 Lakh (down 55% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 55% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.68 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -6.7% | ||||
| Net Profit Margin | -10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Novalitha Pharma Private Limited, buy the company report.
Board of directors of Novalitha Pharma Private Limited
Novalitha Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surya Rao Easarla | Managing Director | 20 Sep 2018 | 8 Years 2 Months | Current |
| Veera Venkata Ramana Easarla | Director | 20 Sep 2018 | 8 Years 2 Months | Current |
Peer comparison
Novalitha Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abhiraj Agencies Private Limited | ₹84.48 Lakh (FY 2019) | 305.0% | Lucknow, Uttar Pradesh, India | |||
| Morzani India Private Limited | ₹84.46 Lakh (FY 2025) | 23.0% | Jalpaiguri, West Bengal, India | |||
| Yogamaaya Arts Pvt Ltd | ₹84.45 Lakh (FY 2025) | -31.0% | Kolkata, West Bengal, India | |||
| Findindeed Private Limited | ₹84.45 Lakh (FY 2022) | 539.0% | Delhi, India | |||
| Shamsheer Food & Chem Private Limited | ₹84.42 Lakh (FY 2025) | 41.0% | Lucknow, Uttar Pradesh, India | |||
| Novalitha Pharma Private Limitedthis company | ₹84.41 Lakh (FY 2023) | -₹8.65 Lakh | -10.2% | -55.0% | Hyderabad, Telangana, India | |
| Anita Distributors Private Limited | ₹84.37 Lakh (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Arjoi Retail Private Limited | ₹84.37 Lakh (FY 2025) | 32.0% | New Delhi, Delhi, India | |||
| Ahrl Homoeo Private Limited | ₹84.34 Lakh (FY 2024) | 74.0% | Kolkata, West Bengal, India | |||
| Pillsgo Healthcare Private Limited | ₹84.32 Lakh (FY 2025) | -15.0% | Aligarh, Uttar Pradesh, India | |||
| Rensel Tech Private Limited | ₹84.31 Lakh (FY 2025) | -14.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Novalitha Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Mar 2020 | 100333517 | Others | ₹27 Lakh | Open |
Total charge records: 1 View all charges
Deals & funding
Novalitha Pharma Private Limited has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9 Lakh; the latest was in February 2021.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Rights issue | ₹30 Lakh | Investors: an individual |
| Mar 2019 | Funding round | ₹9 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Novalitha Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novalitha Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Novalitha Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Novalitha Pharma Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Surya Rao Easarla ceased to be Director on 20 Sep 2021.
Frequently asked questions
Novalitha Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U24303TG2018PTC126911.
Novalitha Pharma has 2 current directors:
- Surya Rao Easarla - Managing Director
- Veera Venkata Ramana Easarla - Director
The latest financial statements of Novalitha Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Novalitha Pharma is U24303TG2018PTC126911. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novalitha Pharma was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Novalitha Pharma has 2 deals on record (1 funding round, 1 rights issue), with disclosed funding of ₹9 Lakh; the latest was in February 2021.
The peers of Novalitha Pharma by revenue are Abhiraj Agencies Private Limited, Morzani India Private Limited, Yogamaaya Arts Pvt Ltd, Findindeed Private Limited, Shamsheer Food & Chem Private Limited and 5 more, all in the same principal business activity (retail trading).
Surya Rao Easarla ceased to be Director on 20 Sep 2021. Surya Rao Easarla was appointed as Managing Director on 20 Sep 2018. Veera Venkata Ramana Easarla was appointed as Director on 20 Sep 2018.
The registered office of Novalitha Pharma is at F – 301 7 – 2 – 1735 And 18135A 3rd Floor Sopanam Enclave Czech Colony Sanath Na, Gar, Hyderabad, Telangana, India – 500018.
Novalitha Pharma operates in the food and beverages industry, in the manufacturing segment.
Novalitha Pharma has open charges of ₹27 Lakh and no satisfied charges on record as per latest MCA filings.

